National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 22,193 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1268 out of 2,220

Result pages: prev   1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277   next


VAERS ID: 1200655 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-23
Onset:2021-03-11
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9598 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood creatinine increased, COVID-19, Drug ineffective, Hyperbilirubinaemia, Respiratory failure, SARS-CoV-2 test
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (broad), Liver related investigations, signs and symptoms (narrow), Cholestasis and jaundice of hepatic origin (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Lack of efficacy/effect (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow), Guillain-Barre syndrome (broad), Chronic kidney disease (broad), Hypersensitivity (broad), Tumour lysis syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-26
   Days after onset: 14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210320; Test Name: Creatinine; Result Unstructured Data: Test Result:increased; Test Date: 20210325; Test Name: Hyperbilirubinaemia; Result Unstructured Data: Test Result:aggravated; Test Date: 20210311; Test Name: TNF SARS-CoV 2; Result Unstructured Data: Test Result:positive
CDC Split Type: ITPFIZER INC2021380160

Write-up: 23Feb I vaccine dose; 11Mar TNF SARS-CoV 2 for pos contact tracking; 20Mar insuff. acute respiratory tract with the need for hospitalization The Patient resides in a country; hyperbilirubinaemia aggravated; creatinine: increased; 23Feb I vaccine dose; 11Mar TNF SARS-CoV 2 for pos contact tracking; 20Mar insuff. acute respiratory tract with the need for hospitalization The Patient resides in a country; 23Feb I vaccine dose; 11Mar TNF SARS-CoV 2 for pos contact tracking; 20Mar insuff. acute respiratory tract with the need for hospitalization The Patient resides in a country; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB [IT-MINISAL02-710342]. A 99-year-old female patient received the first dose of bnt162b2 (COMIRNATY, Lot Number: EP9598; Expiration Date: 30Jun2021), intramuscular, administered in left deltoid (reported as left shoulder) on 23Feb2021 13:12 as single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. On 23Feb2021 the patient had the first vaccine dose of bnt162b2. On 11Mar2021, TNF SARS-COV 2 for positive contact tracing. On 20Mar2021, the patient had insuff. acute respiratory tract (Failure respiratory) with the need for hospitalization as the patient resides in certain area. Actions taken for the events insuff. acute respiratory tract and TNF SARS-COV 2 for positive included oxygen therapy, hydration, steroids. The patient underwent lab tests and procedures which included TNF SARS-CoV 2: positive on 11Mar2021, creatinine: increased on 20Mar2021, and hyperbilirubinaemia aggravated on 25Mar2021. The patient died on 26Mar2021. Cause of death was insuff. acute respiratory tract and TNF SARS-COV 2 for positive. It was unknown if an autopsy was performed. The outcome of the events insuff. acute respiratory tract and TNF SARS-COV 2 for positive was fatal. The outcome of the remaining events was unknown.; Reported Cause(s) of Death: insuff. acute respiratory tract; TNF SARS-COV 2 for positive; TNF SARS-COV 2 for positive


VAERS ID: 1200779 (history)  
Form: Version 2.0  
Age: 37.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-05
Onset:2021-04-08
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9480 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Cardio-respiratory arrest, Pyrexia
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-08
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arrhythmia
Allergies:
Diagnostic Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:37 to 37.9 Centigrade; Comments: after the vaccination
CDC Split Type: JPPFIZER INC2021385050

Write-up: persistent fever in the range of 37 to 37.9 degrees centigrade; Cardio-respiratory arrest; This is a spontaneous report from a contactable physician received from the Agency Regulatory Authority. The regulatory authority report number is v21101088. A 37-year-old male patient received the second dose of BNT162B2 (COMIRNATY), intramuscularly, on 05Apr2021 at 18:00 (Lot Number: ER9480; Expiration Date: 31Jul2021) (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included arrhythmia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient''s concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (COMIRNATY; Lot number: EP9605; Expiration date: 30Jun2021), intramuscularly, on 18Mar2021 at 18:00 (at the age of 37-years-old) for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced cardio-respiratory arrest on 08Apr2021 at 08:00, which was reported as fatal. The patient also experienced persistent fever in the range of 37 to 37.9 degrees centigrade on an unspecified date. The patient underwent lab tests and procedures which included body temperature: 37 to 37.9 centigrade on an unspecified date (after the vaccination). The patient did not receive any treatment as a result of the events. The patient died on 08Apr2021. The cause of death was under investigation and not reported. It was not reported if an autopsy was performed (reported as: scheduled for 09Apr2021). It was also reported that since the vaccination, the patient had not been tested for COVID-19.; Reported Cause(s) of Death: Under investigation


VAERS ID: 1202820 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-03
Onset:2021-03-07
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2163 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-07
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ATPFIZER INC2021380051

Write-up: Myocardial infarction; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number AT-BASGAGES-2021-20935. A 94-year-old female patient received BNT162B2 (COMIRNATY; lot number: EP2163), intramuscular on 03Mar2021 at single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 07Mar2021, the patient died due to myocardial infarction. It was not reported if an autopsy was performed. Sender Comment: BASGAGES-comment: Follow-up information requested. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Myocardial infarction


VAERS ID: 1202833 (history)  
Form: Version 2.0  
Age: 79.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-02-03
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 0004246 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Bronchoalveolar lavage, Computerised tomogram, Death, Decreased appetite, Dyspnoea, Fatigue, Headache, Oxygen saturation, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes mellitus; Ex-tobacco user; Hepatic cirrhosis; Hypothyroidism; Idiopathic pulmonary fibrosis; Osteoporosis; Rheumatoid arthritis
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: Bronchoalveolar lavage; Result Unstructured Data: Severely contaminated with bronchial secretion and blood; Test Date: 2021; Test Name: CT; Result Unstructured Data: CT shows ground glass changes; Test Date: 2021; Test Name: SpO2; Test Result: 85 %; Result Unstructured Data: low; Test Date: 2021; Test Name: COVID-19 test; Test Result: Negative ; Result Unstructured Data: COVID swab 2 x negative
CDC Split Type: CHMODERNATX, INC.MOD20210

Write-up: dyspnea exacerbated; headache; inappetence; fatigue; death; This regulatory authority case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DEATH (death), DYSPNOEA (dyspnea exacerbated), HEADACHE (headache), DECREASED APPETITE (inappetence) and FATIGUE (fatigue) in a 79-year-old female patient who received mRNA-1273 (COVID-19 Vaccine Moderna) (batch no. 0004246) for COVID-19 vaccination. The patient''s past medical history included Ex-tobacco user, Hepatic cirrhosis, Rheumatoid arthritis, Idiopathic pulmonary fibrosis, Diabetes mellitus, Hypothyroidism and Osteoporosis. On 21-Jan-2021, the patient received first dose of mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DEATH (death) (seriousness criterion death), DYSPNOEA (dyspnea exacerbated) (seriousness criterion hospitalization), HEADACHE (headache) (seriousness criterion hospitalization), DECREASED APPETITE (inappetence) (seriousness criterion hospitalization) and FATIGUE (fatigue) (seriousness criterion hospitalization). The patient died on an unknown date. At the time of death, DYSPNOEA (dyspnea exacerbated), HEADACHE (headache), DECREASED APPETITE (inappetence) and FATIGUE (fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Bronchoalveolar lavage: abnormal (abnormal) Severely contaminated with bronchial secretion and blood. In 2021, Computerised tomogram: abnormal (abnormal) CT shows ground glass changes. In 2021, Oxygen saturation: 85 percent (Low) low. In 2021, SARS-CoV-2 test: negative (Negative) COVID swab 2 x negative. For mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular), the reporter considered HEADACHE (headache), DECREASED APPETITE (inappetence) and FATIGUE (fatigue) to be possibly related and DYSPNOEA (dyspnea exacerbated) to be unlikely related. No further causality assessment was provided for DEATH (death). No concomitant medication were reported. No treatment medications were provided. This is a case of death in a 79-year-old female subject with a medical history of Ex-tobacco user, Hepatic cirrhosis, Rheumatoid arthritis, Idiopathic pulmonary fibrosis, Diabetes mellitus, Hypothyroidism and Osteoporosis, who died 18 days after receiving the first dose of vaccine. Based on reporter''s causality of attributing to pulmonary fibrosis exacerbation, the death is assessed as unlikely related to mRNA-1273. No follow up is possible. Reporter did not allow further contact; Sender''s Comments: This is a case of death in a 79-year-old female subject with a medical history of Ex-tobacco user, Hepatic cirrhosis, Rheumatoid arthritis, Idiopathic pulmonary fibrosis, Diabetes mellitus, Hypothyroidism and Osteoporosis, who died 18 days after receiving the first dose of vaccine. Based on reporter''s causality of attributing to pulmonary fibrosis exacerbation, the death is assessed as unlikely related to mRNA-1273. No follow up is possible.


VAERS ID: 1202846 (history)  
Form: Version 2.0  
Age: 92.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-09
Onset:2021-03-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 300042722 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Ischaemic stroke
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-12
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: IMOVANE 3.75 mg; LEVOTHYROXINE SODIUM; LASILIX 40 mg; BISOPROLOL FUMARATE; MONOPROST 50 mg/ml; SIMBRINZA 10 mg/ml + 2 mg/ml; PRAVASTATIN SODIUM
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Fibrillation atrial; Ischaemic heart disease; Subdural haematoma
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRMODERNATX, INC.MOD20210

Write-up: Ischemic stroke; This case was received via Company (Reference number: QTS-210409-125) on 05-Apr-2021 and was forwarded to Moderna on 05-Apr-2021. This regulatory authority case was reported by a physician and describes the occurrence of ISCHAEMIC STROKE (Ischemic stroke) in a 92-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 300042722) for COVID-19 vaccination. The patient''s past medical history included Subdural haematoma, Ischaemic heart disease and Fibrillation atrial. Concomitant products included PRAVASTATIN SODIUM [PRAVASTATIN SODIUM] from an unknown date to 10-Mar-2021 for Dyslipidaemia, LEVOTHYROXINE SODIUM from an unknown date to 10-Mar-2021 for Hypothyroidism, LASILIX 40 mg from an unknown date to 10-Mar-2021 and BISOPROLOL FUMARATE from an unknown date to 10-Mar-2021 for Ischaemic heart disease, IMOVANE 3,75 mg from an unknown date to 10-Mar-2021, MONOPROST 50 mg/ml from an unknown date to 10-Mar-2021 and SIMBRINZA 10 mg/ml and 2 mg/ml from an unknown date to 10-Mar-2021 for an unknown indication. On 09-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 10-Mar-2021, after starting mRNA-1273 (COVID 19 Vaccine Moderna), the patient experienced ISCHAEMIC STROKE (Ischemic stroke) (seriousness criteria death and medically significant). The patient died on 12-Mar-2021. The reported cause of death was Ischemic stroke. It is unknown if an autopsy was performed. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. Concomitant products included PRAVASTATIN SODIUM from an unknown date to 10-Mar-2021 for Dyslipidaemia, LEVOTHYROXINE SODIUM from an unknown date to 10-Mar-2021 for Hypothyroidism, LASILIX 40 mg from an unknown date to 10-Mar-2021 and BISOPROLOL FUMARATE from an unknown date to 10-Mar-2021 for Ischaemic heart disease, IMOVANE 3,75 mg from an unknown date to 10-Mar-2021, MONOPROST 50 mg/ml from an unknown date to 10-Mar-2021 and SIMBRINZA 10 mg/ml + 2 mg/ml from an unknown date to 10-Mar-2021 for an unknown indication. This is a case of death in a 92-year-old male subject with unknown medical history of Subdural hematoma, Ischemic heart disease and Fibrillation atrial, who died 3 days after receiving the first dose of vaccine. Very limited information has been provided at this time. No follow up is possible. Reporter did not allow further contact; Sender''s Comments: This is a case of death in a 92-year-old male subject with unknown medical history of Subdural hematoma, Ischemic heart disease and Fibrillation atrial, who died 3 days after receiving the first dose of vaccine. Very limited information has been provided at this time. No follow up is possible.; Reported Cause(s) of Death: Ischemic stroke


VAERS ID: 1202850 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-02-21
   Days after vaccination:34
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute respiratory distress syndrome, Atrial fibrillation, Blood creatinine, Blood pressure measurement, Body temperature, COVID-19, Cardiomyopathy, Coma scale, Computerised tomogram, Drug ineffective, Echocardiogram, Electrocardiogram, Heart rate, Hypotension, Livedo reticularis, Multiple organ dysfunction syndrome, Oxygen saturation, Renal failure, Respiratory rate, SARS-CoV-2 test, Sepsis, Ventricular hypokinesia
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Interstitial lung disease (broad), Neuroleptic malignant syndrome (broad), Supraventricular tachyarrhythmias (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (narrow), Eosinophilic pneumonia (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Dehydration (broad), Hypokalaemia (broad), Sepsis (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-02
   Days after onset: 9
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: BISOCE; CORTANCYL; DESLORATADINE; ELIQUIS; KARDEGIC; LASILIX [FUROSEMIDE]; METOCLOPRAMIDE; NIVOLUMAB; PERINDOPRIL; PANTOPRAZOLE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Chronic renal failure (basic creatinine = 130 umol / L); Hypertension arterial; Hyperthyroidism (thyroid overload); Ischaemic heart disease (ischemic heart disease with myocardial infarction (MI) in 2018); Lung cancer metastatic (treated by left nephrectomy in 2013 and radiotherapy on pulmonary recurrence); Malignant melanoma excision (operated on in 2016); Mediastinal metastases (treated by left nephrectomy in 2013 and radiotherapy on pulmonary recurrence); Melanoma (operated on in 2016); Metastases to bone (treated by left nephrectomy in 2013 and radiotherapy on pulmonary recurrence); Metastatic renal carcinoma (treated by left nephrectomy in 2013 and radiotherapy on pulmonary recurrence); Myocardial infarction (ischemic heart disease with myocardial infarction (MI) in 2018); Nephrectomy (treated by left nephrectomy in 2013 and radiotherapy on pulmonary recurrence); Pneumocystosis (Pneumocystosis in 2019 treated with BACTRIM, now on pentamidine for prophylaxis); Radiotherapy (treated by left nephrectomy in 2013 and radiotherapy on pulmonary recurrence); Renal carcinoma (with pleural involvement treated with pazobanib then nivolumab since Jun2018)
Allergies:
Diagnostic Lab Data: Test Date: 20210225; Test Name: Creatinine; Result Unstructured Data: Test Result:137 umol/l; Test Date: 20210222; Test Name: blood pressure; Result Unstructured Data: Test Result:80/40 mmHg; Test Date: 20210222; Test Name: body temperature; Result Unstructured Data: Test Result:38.9 Centigrade; Test Date: 20210225; Test Name: Glasgow; Result Unstructured Data: Test Result:15; Test Date: 20210222; Test Name: Thoraco-abdominal CT scan; Result Unstructured Data: Test Result:COVID19 infection extended to 25% of the lung pare; Comments: COVID19 infection extended to 25% of the lung parenchyma.; Test Date: 20210301; Test Name: Echocardiography; Result Unstructured Data: Test Result:myocardial astonishment with global hypokinesia wi; Comments: myocardial astonishment with global hypokinesia without recovery on the iterative ultrasounds performed.; Test Date: 20210225; Test Name: ECG; Result Unstructured Data: Test Result:: atrial fibrillation with appearance of right bun; Comments: atrial fibrillation with appearance of right bundle branch block.; Test Date: 20210222; Test Name: Heart rate; Result Unstructured Data: Test Result:83 bpm; Test Date: 20210222; Test Name: Heart rate; Result Unstructured Data: Test Result:76 bpm; Test Date: 20210225; Test Name: Heart rate; Result Unstructured Data: Test Result:150 bpm; Test Date: 20210225; Test Name: Heart rate; Result Unstructured Data: Test Result:104 bpm; Test Date: 20210225; Test Name: saturation; Test Result: 87 %; Comments: under non-invasive ventilation (NIV); Test Date: 20210225; Test Name: respiratory; Result Unstructured Data: Test Result:polypneic at 45 / min; Test Date: 20210221; Test Name: PCR COVID19; Test Result: Positive
CDC Split Type: FRPFIZER INC2021380214

Write-up: multiple organ failure with acute respiratory distress syndrome (ARDS) severe; multiple organ failure with acute respiratory distress syndrome (ARDS) severe; myocardial astonishment and renal failure on dialysis; myocardial astonishment with global hypokinesia/myocardial astonishment and renal failure on dialysis; myocardial astonishment with global hypokinesia; AFib; arterial hypotension (blood pressure 80/40 mmHg); mottling/Diffuse mottling of the lower limbs and trunk.; sepsis with fever at 38.9C; PCR COVID19 positive; PCR COVID19 positive; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority FR-AFSSAPS-LY20211640. This is a report received from the Regulatory Authority. A 77-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 18Jan2021 as single dose (lot EM0477); and dose 2 intramuscular on 15Feb2021 as single dose (lot EK9788), for COVID-19 vaccination. Medical history included metastatic renal carcinoma in the lung, mediastinum and bone treated by left nephrectomy in 2013 and radiotherapy on pulmonary recurrence, new recurrence of renal carcinoma in 2017 with pleural involvement initially treated with pazobanib then nivolumab since Jun2018, pneumocystosis in 2019 treated with bactrim, now on pentamidine for prophylaxis, chronic renal failure (basic creatinine was 130umol / L), melanoma (operated on in 2016), ischemic heart disease with myocardial infarction (MI) in 2018, hypertension arterial, complete arrhythmia by atrial fibrillation, Hyperthyroidism (thyroid overload), and long-term corticosteroid therapy in a context of colitis under immunotherapy - corticosteroids a priori suddenly stopped suddenly recently. History of COVID19 was not specified. Concomitant medications included bisoprolol fumarate (BISOCE), prednisone (CORTANCYL), desloratadine (DESLORATADINE), apixaban (ELIQUIS), acetylsalicylate lysine (KARDEGIC), furosemide (LASILIX), metoclopramide, nivolumab, perindopril and pantoprazole. On 19Feb2021, the patient experienced fever, body aches, chills, headache, digestive disorders. On 21Feb2021, the patient had a PCR COVID-19 positive. On 22Feb2021, the patient presented to the emergency room with the persistence of fever and the appearance of rapidly progressive dyspnea. In the emergency room, a picture of sepsis with fever at 38.9C, mottling, arterial hypotension (blood pressure 80/40 mmHg) which rises after vascular filling. Oxygen request was at 3 L / min with no sign of respiratory distress. Thoraco-abdominal CT scan showed COVID19 infection extended to 25% of the lung parenchyma. Start ceftriaxone and rovamycin + an injection of amikacin. Hydrocortisone EPS in the face of suspected acute adrenal insufficiency (sudden stop of chronic corticosteroid therapy). On 22Feb2021: heart rate was 83 bpm, and 76 bpm. On 24Feb2021, heart rate was at 83 bpm. On 25Feb2021, sudden respiratory degradation and was resuscitation. Respiratory: polypneic at 45 / min, 87% saturation under non-invasive ventilation (NIV). Hemodynamically: stable except amine. Patient had diffuse mottling of the lower limbs and trunk and cold ends. Cardiovascular: tachycardia at 150 bpm and ECG: atrial fibrillation with appearance of right bundle branch block. Neurologically: Glasgow 15 On the digestive level: supple and painless abdomen. On the renal level: no urinary functional signs. Creatinine 137umol / L. Before the sudden onset of distress and the surge of complete arrhythmia by atrial fibrillation, a cardiac origin to the respiratory distress was suspected. Treatment of challenge with furosemide, maintenance of NIV, slowing of complete arrhythmia by atrial fibrillation with amiodarone and magnesium. There was no improvement after one hour, patient was intubated + noradrenaline. Reduced atrial fibrillation on 27Feb2021 with amiodarone ESP. Curative anticoagulation by Calciparin. Probable acute coronary syndrome (ACS) type 2. On 25Feb2021, heart rate was at 104bpm. On 01Mar2021, echocardiography showed myocardial astonishment with global hypokinesia without recovery on the iterative ultrasounds performed. On 02Mar2021, there was multiple organ failure with acute respiratory distress syndrome (ARDS) severe, myocardial astonishment and renal failure on dialysis which led to discontinuation of active therapies. Outcome of event AFib was not recovered; and outcome of the rest of the events was unknown. The patient died on 02Mar2021 due to PCR COVID19 positive. It was unknown if autopsy was performed.; Reported Cause(s) of Death: PCR COVID19 positive; PCR COVID19 positive


VAERS ID: 1202857 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-17
Onset:2021-03-18
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET1831 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Cardio-respiratory arrest, Cough, Dyspnoea, Haemoptysis, Pyrexia, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-21
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: MODOPAR; AMLOR; HYTACAND; MELATONIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension; Parkinson''s disease
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021380267

Write-up: Cardio-respiratory arrest; faintness; massive hemoptysis; asthenia; Fever; Cough; Dyspnoea; This is a spontaneous report from contactable physician downloaded from a regulatory authority-WEB FR-AFSSAPS-PS20210705. A 75-year-old male patient received the first dose of BNT162b2 (COMIRNATY, Batch/Lot Number: ET1831), intramuscular, administered in arm left on 17Mar2021 as a single dose for COVID-19 immunisation. Medical history included Parkinson''s disease and hypertension from an unknown date and unknown if ongoing. Concomitant medications included benserazide hydrochloride, levodopa (MODOPAR), amlodipine besilate (AMLOR), candesartan cilexetil, hydrochlorothiazide (HYTACAND) and melatonin taken for an unspecified indication, start and stop date were not reported. Clinical course was as follows: The day of the injection: no fever, no vaccine contraindication for vaccination with the Pfizer vaccine. The immediate end of the vaccination took place without any particular event, as well the night following the injection. On 18Mar2021, the day after the vaccination: onset of a cough that was initially dry then worsening and becoming "oily and taking on the lungs" (as reported) associated with difficulty of breathing. Taking oxomemazine (TOPLEXIL) cough syrup and paracetamol in the presence of an associated fever (not measured): "the patient was suffocating with heat" (as reported). Faced with the worsening of the cough, associated with asthenia, the subject call from doctor on Saturday, 20Mar2021. Thirty (30) minutes after the call: no doctor came. Call from the emergent medical services on the night of 20 to 21Mar2021: worsening of the patient''s state of health, he was no longer breathing and appeared to be dead. By telephone, the medical regulator requested the implementation of an emergency maneuver (cardiac massage by the patient''s friend for about ten minutes before the arrival of the EMS) which would have triggered massive hemoptysis ("he spat a lot of blood while coughing"). The patient''s friend is then relayed by the EMS team (8 people), for about 2 hours (resuscitation procedures, cardiac massage). The patient''s death after massive hemoptysis was observed on 21Mar2021 at 6:15 am at home, 4 days after the first injection of COMIRNATY. The death certificate mentioned "the absence of medico-legal obstacles (as reported). The causes of death mentioned are cardiopulmonary arrest, following a faintness and a fatty cough evolving for 48 hours. Apparent circumstances of death: natural death. Additional information: No PCR was performed at the time of the onset of the fatty cough. Note that the patient''s friend performed a PCR one week after death, which came back negative (as reported). Absolutely independent patient, living at home. Seen by his neurologist and his occupational doctor a week before the death: everything was fine. No history of arrhythmias. No recent change in treatment except the increase in melatonin for sleep disorders. No other specific complaints. No decompensation of a chronic pathology. No possible signs of anaphylactic manifestation shortly before death. Death from cardio-respiratory arrest occurring 4 days after vaccination, following difficulty in breathing associated with a fatty cough and fever. 1) From a chronological point of view, the data do not allow to exclude the role of the anti-Covid19 vaccine in the occurrence of this death, the cause of which remains however unidentified to this day and which occurs four days after the vaccination. 2) On the semiological level, in the absence of an autopsy, the cause of this death is not identified. The hypothesis of a pulmonary infection (COVID?) can be raised (as reported). The outcome of the events was fatal. The patient died on 21Mar2021. Cause of death was also reported as fever, cough, dyspnoea, asthenia, massive hemoptysis, cardiopulmonary arrest, following a faintness and a fatty cough. An autopsy was not performed. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: In absence of autopsy report, due to a positive drug-event temporal association, the company cannot completely exclude a causal association between Comirnaty administration and the reported events, at the present time, all qualified as fatal. The impacts of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: cardiopulmonary arrest; faintness; fatty cough; asthenia; massive hemoptysis; fever; Dyspnoea


VAERS ID: 1202862 (history)  
Form: Version 2.0  
Age: 87.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-17
Onset:2021-03-18
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3000494 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Mouth haemorrhage, Pyrexia
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-19
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LASITONE; DUOPLAVIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITMODERNATX, INC.MOD20210

Write-up: Mild febrile episode the day after vaccination, death overnight, blood stains found at labial commisure; blood stains found at labial commisure; Mild febrile episode the day after vaccination; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Apr-2021 and was forwarded to Moderna on 01-Apr-2021. This regulatory authority case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DEATH (Mild febrile episode the day after vaccination, death overnight, blood stains found at labial commisure) in an 87-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 3000494) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included No adverse event. Previously administered products included for Product used for unknown indication: GASTROLOC - "20 MG COMPRESSE GASTRORESISTENTI" 14 COMPRESSE IN BLISTER AL/OPA/AL/PVC (GLAX and FOSTER (CHIESI FARMACEUTICI S.P.A.) (R03AK08). Past adverse reactions to the above products included No adverse reaction with FOSTER (CHIESI FARMACEUTICI S.P.A.) (R03AK08) and GASTROLOC - "20 MG COMPRESSE GASTRORESISTENTI" 14 COMPRESSE IN BLISTER AL/OPA/AL/PVC (GLAX. Concomitant products included ACETYLSALICYLIC ACID, CLOPIDOGREL BISULFATE (DUOPLAVIN) from 06-Jul-2016 to 19-Mar-2021 for Atherothrombosis prophylaxis, FUROSEMIDE, SPIRONOLACTONE (LASITONE) from 01-Aug-2012 to 19-Mar-2021 for an unknown indication. On 17-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form in total. On 18-Mar-2021, after starting mRNA-1273 (COVID 19 Vaccine Moderna), the patient experienced PYREXIA (Mild febrile episode the day after vaccination). On 19-Mar-2021, the patient experienced MOUTH HAEMORRHAGE (blood stains found at labial commisure). The patient died on 19-Mar-2021. The cause of death was not reported. It is unknown if an autopsy was performed. At the time of death, MOUTH HAEMORRHAGE (blood stains found at labial commisure) and PYREXIA (Mild febrile episode the day after vaccination) outcome was unknown. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. Per the patient''s family, the patient was in a state of well-being at the time of vaccination. Treatment information was not provided. Company comment: Very limited information regarding these events has been provided at this time. Patient''s age along with unknown underlying conditions may have been contributory for the occurrence of the death. No further follow-up information is expected. Reporter did not allow further contact; Reported Cause(s) of Death: Death


VAERS ID: 1202866 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-31
Onset:2021-03-31
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Chest pain
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: CVA
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021380148

Write-up: In the late afternoon, abdominal pain; In the late afternoon, retrosternal pain; This is a spontaneous report from a contactable physician downloaded from the regulatory authority with regulatory authority number IT-MINISAL02-710033. An 85-year-old female patient received bnt162b2 (COMIRNATY reported as COVID 19 COMIRNATY VACCINE (PFIZER) * 195FL 0,45ML), dose 1 via an unspecified route of administration on 31Mar2021 13:52 (Lot Number: ET7205) as single dose for covid-19 immunisation. Medical history included CVA (cerebrovascular accident) from 01Jan2017 to an unknown date. The patient''s concomitant medications were not reported. It was reported that in the late afternoon (31Mar2021), the patient abdominal and retrosternal pain. It was reported that the patient was intubated, massaged and received drug treatment. The patient was transported to Emergency Room (ER). The outcome of the events was fatal. The patient died on 31Mar2021. It was not reported if an autopsy was performed. Sender Comment: 02Apr2021 Regional Pharmacovigilance Center: requests for follow-up information from the reporter regarding clinical report and case management. Waiting. Reporter comment: Sent by specific profile No follow-up attempts possible. No information expected.; Reporter''s Comments: Sent by specific profile; Reported Cause(s) of Death: abdominal pain; Retrosternal pain


VAERS ID: 1202869 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-14
Onset:2021-03-14
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP6775 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Loss of consciousness, Respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Respiratory failure (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-14
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: MXPFIZER INC2021386375

Write-up: Loses consciousness; Find him out of breath; This is a spontaneous report received from a regulatory authority. The regulatory authority report number is 5813-4. A non-contactable healthcare professional reported that a 76-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EP6775, Expiration Date: 01Jun2021), intramuscular in left arm, on 14Mar2021 at 08:15 AM, at a single dose, for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient was healthy before vaccination. The patient received a dose of BNT162B2 at 8:15 AM without incident during his waiting time. The patient retires to his home where he takes a meal and sits in a garden chair where his relatives observe that he loses consciousness and when they approach to check they find him out of breath at 09:00 AM (45 minutes after the first dose on 14Mar2021). A neighbor approaches to give him CPR maneuvers without change after the intervention. The relatives go again to the healthcare professional to report what happened. The outcome of the events was fatal. The patient died on 14Mar2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Find him out of breath; Loses consciousness


Result pages: prev   1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1268&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166